Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia

被引:0
|
作者
A Sanchez-Aguilera
I Rattmann
D Z Drew
L U W Müller
V Summey
D M Lucas
J C Byrd
C M Croce
Y Gu
J A Cancelas
P Johnston
T Moritz
D A Williams
机构
[1] Cincinnati Children's Hospital Medical Center,Division of Experimental Hematology
[2] Children's Hospital Boston,Division of Hematology/Oncology
[3] Ohio State University,Division of Hematology & Oncology
[4] Immunology and Medical Genetics,Department of Molecular Virology
[5] Ohio State University,Department of Internal Medicine (Cancer Research)
[6] Clinical Research Program,undefined
[7] Children's Hospital Boston,undefined
[8] West German Cancer Center,undefined
[9] University of Duisburg-Essen Medical School,undefined
来源
Leukemia | 2010年 / 24卷
关键词
RhoH GTPase; chronic lymphocytic leukemia; TCL1; B cells; lymphopoiesis;
D O I
暂无
中图分类号
学科分类号
摘要
RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family that functions as a regulator of thymocyte development and T-cell receptor signaling by facilitating localization of zeta-chain-associated protein kinase 70 (ZAP70) to the immunological synapse. Here we investigated the function of RhoH in the B-cell lineage. B-cell receptor (BCR) signaling was intact in Rhoh−/− mice. Because RhoH interacts with ZAP70, which is a prognostic factor in B-cell chronic lymphocytic leukemia (CLL), we analyzed the mRNA levels of RhoH in primary human CLL cells and showed a 2.3-fold higher RhoH expression compared with normal B cells. RhoH expression in CLL positively correlated with the protein levels of ZAP70. Deletion of Rhoh in a murine model of CLL (Eμ-TCL1Tg mice) significantly delayed the accumulation of CD5+IgM+ leukemic cells in peripheral blood and the leukemic burden in the peritoneal cavity, bone marrow and spleen of Rhoh−/− mice compared with their Rhoh+/+ counterparts. Phosphorylation of AKT and ERK in response to BCR stimulation was notably decreased in Eμ-TCL1Tg;Rhoh−/− splenocytes. These data suggest that RhoH has a function in the progression of CLL in a murine model and show RhoH expression is altered in human primary CLL samples.
引用
收藏
页码:97 / 104
页数:7
相关论文
共 50 条
  • [41] Development of High-Grade B-Cell Lymphoma Concurrent with T-Cell Chronic Lymphocytic Leukemia in a Dog
    Okawa, Takumi
    Hiraoka, Hiroko
    Wada, Yuko
    Baba, Kenji
    Itamoto, Kazuhito
    Mizuno, Takuya
    Okuda, Masaru
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2012, 74 (05) : 677 - 680
  • [42] B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma involving bone marrow with an interfollicular pattern
    Kim, YS
    Ford, RJ
    Faber, JA
    Bell, RH
    Elenitoba-Johnson, KSJ
    Medeiros, LJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (01) : 41 - 46
  • [43] Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
    Madanat, Yazan F.
    Smith, Mitchell R.
    Almasan, Alexandru
    Hill, Brian T.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2016, 6 : 1 - 6
  • [44] Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia
    Jamali, Arsia
    Nemovi, Khashayar
    Kaur, Jaspreet
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (05) : 1218 - 1221
  • [45] An unusual case of indolent B-cell lymphoma with distinct chronic lymphocytic leukemia and marginal zone differentiation according to the site of involvement
    Baseggio, L
    Gazzo, S
    Callet-Bauchu, E
    Traverse-Glehen, A
    Thieblemont, C
    Bryon, PA
    Magaud, JP
    Berger, F
    Felman, P
    LEUKEMIA & LYMPHOMA, 2005, 46 (09) : 1369 - 1374
  • [46] B-Cell Receptor Epitope Recognition Correlates With the Clinical Course of Chronic Lymphocytic Leukemia
    Binder, Mascha
    Mueller, Fabian
    Jackst, Antje
    Lechenne, Barbara
    Pantic, Milena
    Bacher, Ulrike
    Eulenburg, Christine Zu
    Veelken, Hendrik
    Mertelsmann, Roland
    Pasqualini, Renata
    Arap, Wadih
    Trepel, Martin
    CANCER, 2011, 117 (09) : 1891 - 1900
  • [47] CD5 ANTIGEN EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    BROHEE, D
    CAUCHIE, P
    NEVE, P
    MEDICAL ONCOLOGY, 1994, 11 (3-4): : 137 - 138
  • [48] The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia
    Rybka, Justyna
    Butrym, Aleksandra
    Wrobel, Tomasz
    Jazwiec, Bozena
    Bogucka-Fedorczuk, Aleksandra
    Poreba, Rafal
    Kuliczkowski, Kazimierz
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 : S147 - S150
  • [49] Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A
    Furtado, F. M.
    Scheucher, P. S.
    Santana, B. A.
    Scatena, N. F.
    Calado, R. T.
    Rego, E. M.
    Matos, D. M.
    Falcao, R. P.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2017, 50 (05)
  • [50] Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: the promise of entospletinib
    Sharman, Jeff
    Di Paolo, Julie
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (03) : 157 - 170